- Report
- April 2022
- 632 Pages
Global
From €2314EUR$2,500USD£1,946GBP
- Drug Pipelines
- August 2020
- 35 Pages
Global
From €1851EUR$2,000USD£1,557GBP
- Report
- May 2025
- 45 Pages
Global
From €273EUR$295USD£230GBP
- Report
- February 2022
- 80 Pages
Africa
From €1851EUR$2,000USD£1,557GBP
- Report
- February 2022
- 40 Pages
Brazil
From €1388EUR$1,500USD£1,168GBP
- Report
- February 2022
- 40 Pages
China
From €1388EUR$1,500USD£1,168GBP
- Report
- February 2022
- 40 Pages
France
From €1388EUR$1,500USD£1,168GBP
- Report
- February 2022
- 40 Pages
Germany
From €1388EUR$1,500USD£1,168GBP
- Report
- February 2022
- 40 Pages
Ireland
From €1388EUR$1,500USD£1,168GBP
- Report
- February 2022
- 40 Pages
Japan
From €1388EUR$1,500USD£1,168GBP
- Report
- February 2022
- 40 Pages
Russia
From €1388EUR$1,500USD£1,168GBP
- Report
- February 2022
- 40 Pages
South Korea
From €1388EUR$1,500USD£1,168GBP
- Report
- February 2022
- 40 Pages
United States
From €1388EUR$1,500USD£1,168GBP
- Report
- February 2022
- 40 Pages
Vietnam
From €1388EUR$1,500USD£1,168GBP
- Report
- December 2021
- 40 Pages
Vietnam
From €1388EUR$1,500USD£1,168GBP
- Report
- December 2021
- 40 Pages
United States
From €1388EUR$1,500USD£1,168GBP
- Report
- December 2021
- 40 Pages
South Korea
From €1388EUR$1,500USD£1,168GBP
- Report
- December 2021
- 40 Pages
Russia
From €1388EUR$1,500USD£1,168GBP
- Report
- December 2021
- 40 Pages
Japan
From €1388EUR$1,500USD£1,168GBP
- Report
- December 2021
- 40 Pages
Ireland
From €1388EUR$1,500USD£1,168GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more